Loading…
5 companies · GEL, thousands · columns ordered by revenue
| Line item | In Vitro Laipi | University Clinic of In… | Davit Tatishvilis Janmr… | Pirveli Sameditsino Kli… | Davit Abuladzis Kartul-… |
|---|---|---|---|---|---|
| Total Revenue | 6,467 | 5,668 | 5,235 | 4,761 | 4,479 |
| Total COGS | -4,532 | -777 | -3,745 | -344 | -226 |
| Gross Profit | 1,935 | 4,891 | 1,490 | 4,418 | 4,253 |
| Gross Margin | 29.9% | 86.3% | 28.5% | 92.8% | 95.0% |
| Total Operating Expenses | -509 | -2,715 | -1,090 | -3,944 | -3,542 |
| EBITDA | 1,426 | 2,832 | 400 | 474 | 711 |
| EBITDA Margin | 22.1% | 50.0% | 7.6% | 10.0% | 15.9% |
| Total D&A | -152 | -1,795 | -406 | -415 | -83 |
| EBIT / Operating Income | 1,274 | 1,037 | -6 | 58 | 628 |
| Total Interest Income | 47 | 799 | — | 23 | — |
| Total Interest Expense | -7 | -798 | -265 | -528 | — |
| Profit Before Tax | 1,315 | 1,044 | -149 | -446 | 631 |
| Total Income Tax | 0 | 0 | 0 | 0 | -78 |
| Net Profit / (Loss) | 1,315 | 1,044 | -149 | -446 | 553 |
| Net Margin | 20.3% | 18.4% | -2.9% | -9.4% | 12.3% |
| Other Operating Income | — | 656 | — | — | — |
| Total Other Income | — | 6 | 122 | — | 3 |
| Other Comprehensive Income | — | — | — | — | -16 |
| Total Comprehensive Income | — | — | — | — | 537 |
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| University Clinic of In… | Healthcare Services | 50.0% | 97th pct | 268 |
| In Vitro Laipi | Healthcare Services | 22.1% | 80th pct | 268 |
| Davit Abuladzis Kartul-… | Healthcare Services | 15.9% | 68th pct | 268 |
| Pirveli Sameditsino Kli… | Healthcare Services | 10.0% | 51st pct | 268 |
| Davit Tatishvilis Janmr… | Healthcare Services | 7.6% | 44th pct | 268 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.